How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/primary-hypogonadism-due-to-bilateral-torsion.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Primary Hypogonadism due to Bilateral Torsion — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Primary Hypogonadism due to Bilateral Torsion (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Primary Hypogonadism due to Bilateral Torsion, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Testred	METHYLTESTOSTERONE	Bausch Health	Androgen [EPC]	Androgen receptor	1973-01-01
Androgel	TESTOSTERONE	Besins Hlthcare	Androgen [EPC]	Androgen receptor	1972-01-01
Testosteron	Testosteron	Gulhane School of Medicine		Corticosteroid-binding globulin, Alpha-synuclein, Lanosterol 14-alpha demethylase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 2 drugs in Primary Hypogonadism due to Bilateral Torsion
Bausch Health · 1 drug in Primary Hypogonadism due to Bilateral Torsion
Besins Hlthcare · 1 drug in Primary Hypogonadism due to Bilateral Torsion
Gulhane School of Medicine · 1 drug in Primary Hypogonadism due to Bilateral Torsion

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Primary Hypogonadism due to Bilateral Torsion:

Cite this brief

Drug Landscape (2026). Primary Hypogonadism due to Bilateral Torsion — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/primary-hypogonadism-due-to-bilateral-torsion. Accessed 2026-06-10.

Primary Hypogonadism due to Bilateral Torsion full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing